ghk-cu copper content percentage Peptide GHK-Cu | Copper Peptide Face

11/7/2016 - Health Canada has indicated a potential link to respiratory depressionincluding sedation, somnolence, and loss of consciousnessin patients treated with gabapentin , particularly in patients having lung, kidney, or nervous system diseases that impact breathing, as well as in those that are elderly, or using other drugs that can affect breathing such as opioids, or in those are at higher risk of serious breathing problems

Zhang Q, Lv X-Y, Yang Y-M

None of the peptides listed are intended for human consumption, clinical treatment, or self-administration

However, its important to have a maintenance plan in place

doi: 10.3389/fimmu.2023.1048790 Received 21 September 2022 Accepted 27 February 2023 Published 13 March 2023 Volume 14 - 2023 Edited by Masato Kubo, Tokyo University of Science, Japan Reviewed by Mahzad Akbarpour, University of Chicago Medicine, United States